Nasdaq Gnft News Today

Genfit (NASDAQ:GNFT – Get Free Report) and Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, valuation, earnings, profitability, institutional ownership, risk and dividends. Institutional & Insider Ownership 8.8% of Genfit shares are […]

Genfit (NASDAQ:GNFT – Get Free Report) and Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, profitability, earnings, institutional ownership, valuation and risk. Volatility and Risk Genfit has a beta of 1.08, […]

Genfit S.A. (NASDAQ:GNFT – Free Report) – Research analysts at Leerink Partnrs issued their FY2026 earnings per share (EPS) estimates for Genfit in a report issued on Monday, February 5th. Leerink Partnrs analyst T. Smith anticipates that the company will post earnings per share of ($0.67) for the year. The consensus estimate for Genfit’s current […]

Genfit (NASDAQ:GNFT – Get Free Report) and Curis (NASDAQ:CRIS – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, profitability, earnings, dividends, analyst recommendations, valuation and institutional ownership. Valuation & Earnings This table compares Genfit and Curis’ […]

HC Wainwright reaffirmed their buy rating on shares of Genfit (NASDAQ:GNFT – Free Report) in a research report released on Friday morning, Benzinga reports. HC Wainwright currently has a $11.00 target price on the stock. Genfit Price Performance GNFT stock opened at $3.43 on Friday. Genfit has a 1-year low of $2.89 and a 1-year […]

HC Wainwright restated their buy rating on shares of Genfit (NASDAQ:GNFT – Free Report) in a report issued on Friday morning, Benzinga reports. The brokerage currently has a $11.00 target price on the stock. Genfit Trading Up 7.2 % Shares of NASDAQ:GNFT opened at $3.43 on Friday. The company’s fifty day moving average price is […]

Genfit S.A. (NASDAQ:GNFT – Get Free Report) was the target of a significant drop in short interest in the month of September. As of September 30th, there was short interest totalling 114,300 shares, a drop of 8.1% from the September 15th total of 124,400 shares. Based on an average daily volume of 26,800 shares, the […]

HC Wainwright reissued their buy rating on shares of Genfit (NASDAQ:GNFT – Free Report) in a research note released on Thursday morning, Benzinga reports. They currently have a $11.00 target price on the stock. Genfit Trading Down 0.6 % Shares of GNFT stock opened at $3.35 on Thursday. The company’s 50-day moving average price is […]

Genfit S.A. (NASDAQ:GNFT – Get Free Report) was the recipient of a large decrease in short interest in the month of August. As of August 31st, there was short interest totalling 104,000 shares, a decrease of 10.2% from the August 15th total of 115,800 shares. Currently, 0.2% of the shares of the company are short […]

Genfit S.A. (NASDAQ:GNFT – Get Free Report) fell 6.1% during mid-day trading on Monday . The stock traded as low as $3.57 and last traded at $3.57. 5,229 shares traded hands during trading, a decline of 89% from the average session volume of 47,872 shares. The stock had previously closed at $3.80. Analyst Ratings Changes […]